Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus enoxaparin for venous thromboembolism prophylaxis after lower limb immobilization
ACTRN12626001254381Phase 3Recruiting
- Sponsor
- John Hunter Hospital
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in venous thromboembolism (VTE) comparing Enoxaparin arm with Aspirin arm (2 arms). Primary endpoint: Development of venous thromboembolism. Started Oct 2023; status: recruiting.
02
Drugs
aspirinenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ACTRN12626001254381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626001254381.